Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

NCT02332902 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis 1

Interventions

DRUG: Everolimus

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]